Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D

Nursing and Health Professions

• Ascites 66%
• Aspartate Aminotransferase 16%
• Biological Marker 100%
• Brain Disease 16%
• Child Pugh Score 33%
• Cholinesterase 66%
• Cholinesterase Blood Level 100%
• Chronic Hepatitis 100%
• Chronic Liver Disease 33%
• Delta Agent Hepatitis 100%
• Disease Model 16%
• End Stage Liver Disease 83%
• International Normalized Ratio 33%
• Liver Cirrhosis 33%
• Liver Function Test 16%
• Model For End Stage Liver Disease Score 33%
• Receiver Operating Characteristic 33%
• Serum Albumin 16%

Medicine and Dentistry

• Anticipation 71%
• Ascites 57%
• Aspartate Aminotransferase 14%
• Biological Marker 100%
• Brain Disease 14%
• Child-Pugh Score 28%
• Cholinesterase 100%
• Chronic Hepatitis 100%
• Chronic Liver Disease 28%
• Cross Sectional Study 14%
• Disease Model 14%
• Hepatitis D 100%
• Liver Cirrhosis 28%
• Liver Function 14%
• Liver Function Test 14%
• Model For End Stage Liver Disease Score 28%
• Model for End-Stage Liver Disease 71%
• Platelet 14%
• Retrospective Study 14%
• Serum Albumin 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Ascites 57%
• Aspartate Aminotransferase 14%
• Biological Marker 100%
• Brain Disease 14%
• Cholinesterase 100%
• Chronic Hepatitis 100%
• Chronic Liver Disease 28%
• Cross Sectional Study 14%
• Delta Agent Hepatitis 100%
• Disease Model 14%
• End Stage Liver Disease 100%
• Liver Cirrhosis 28%
• Retrospective Study 14%
• Serum Albumin 14%